InvestorsHub Logo

ranjo

06/15/22 6:35 PM

#380418 RE: sstyles #380410

i would imagine when they see quite a few abstains which would be a change from the past annuals they will get the message that Denner/Sarrisa has a following beyond their own respective shares. I would think the strategy would be to partner with a big name in the cardio space in EU and then buy time to get the combo drug on the market say in 5 years ... i don't see this as a genius move but a proven strategy that has benefitted many no name pharma's to gain traction in the cvd space. milking the free shares atm with no substantial increase in shareholder value needs to stop. I called the 203 number and spoke to a gal that took my phone # and number of shares owned.